ADM’s Fibersol Receives TGA Approval for Use in Health Products in Australia

ADM announced that its Fibersol line of soluble prebiotic fibers has received Therapeutic Goods Administration (TGA) approval for use as an active ingredient in biologicals, listed medicines, and prescription products. This expands Fibersol’s applications beyond food and beverages into dietary supplements and regulated health products, allowing brands to highlight its clinically supported benefits on packaging and strengthen consumer trust.

Supported by over 100 scientific publications, Fibersol promotes beneficial gut bacteria, supports digestive health, nourishes intestinal flora, and may aid appetite regulation by influencing GLP-1 and peptide YY. Fibersol-2 is also associated with reduced sugar and triglyceride absorption. It is versatile, heat- and acid-stable, and neutral in taste, making it suitable for foods, beverages, and supplements.

With Australia’s prebiotics market projected to grow at 17.6% CAGR through 2030 and rising consumer interest in digestive health, ADM’s TGA approval reinforces its commitment to science-backed solutions for functional nutrition.

30-10-2025